Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto Cardiac Amyloidosis Survey
CONCLUSIONS: We confirmed the incidence of ATTR-CM in Kumamoto and the diagnostic approach used in patients with ATTR-CM. Further prospective studies with a larger sample are needed to validate our results and to further shed light on the epidemiology of ATTR-CM in Japan.PMID:35078683 | DOI:10.1016/j.jjcc.2022.01.002 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 26, 2022 Category: Cardiology Authors: Seiji Takashio Takanori Tokitsu Masakazu Matsukawa Naritsugu Sakaino Kazuteru Fujimoto Tomohiro Sakamoto Katsuo Noda Ryusuke Tsunoda Ikuo Misumi Nobutaka Hirai Hideki Doi Shunichi Koide Yuji Mizuno Toyoki Hirose Hirofumi Kurokawa Ichiro Kajiwara Keisuke O Source Type: research

In-hospital adverse events in low-risk patients with acute myocardial infarction - Potential implications for earlier discharge
CONCLUSION: In patients with acute MI with low GRACE and/or CADILLAC risk scores who were free from acute events within 3 days, early discharge after primary percutaneous coronary intervention may be feasible and safe.PMID:35078684 | DOI:10.1016/j.jjcc.2022.01.003 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 26, 2022 Category: Cardiology Authors: Takanori Sato Yuichi Saito Tadahiro Matsumoto Daichi Yamashita Kan Saito Shinichi Wakabayashi Hideki Kitahara Koichi Sano Yoshio Kobayashi Source Type: research

COVID-19 and arrhythmia: An overview
J Cardiol. 2021 Dec 1:S0914-5087(21)00341-5. doi: 10.1016/j.jjcc.2021.11.019. Online ahead of print.ABSTRACTArrhythmias in COVID-19 patients are associated with hypoxia, myocardial ischemia, cytokines, inflammation, electrolyte abnormalities, pro-arrhythmic or QT-prolonging medications, and underlying heart conditions such as severe congestive heart failure, inherited arrhythmia syndromes, or congenital heart conditions. In the pediatric population, multisystem inflammatory syndrome can lead to cardiac injury and arrhythmias. In addition, arrhythmias and cardiac arrests are most prevalent in the critically ill intensive ca...
Source: Journal of Cardiology - January 25, 2022 Category: Cardiology Authors: Joseph A Varney Vinh S Dong Tiffany Tsao Mariam S Sabir Amanda T Rivera Suhaib Ghula Kevin Emmanuel Moriles Mohana Laasya Cherukuri Rahim Fazal Chelsea B Azevedo Rana Mk Mohamed Garrett R Jackson Shannon E Fleming Diana E Rochez Kirellos S Abbas Jaffer H Source Type: research

Low-density lipoprotein receptor and apolipoprotein A 5, myocardial infarction biomarkers in plasma-derived exosomes
CONCLUSION: Exosomal APOA5 and LDLR are intimately associated with MI, and thereby have the potential to function as diagnostic markers of MI.PMID:35058120 | DOI:10.1016/j.jjcc.2021.10.020 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 21, 2022 Category: Cardiology Authors: Yue He Xinsheng Gu Ying Hu Hao Jia Zhibo Zhao Haisong Jiang Hongchao Zheng Fu Zhu Source Type: research

Lifetime management for aortic stenosis: Planning for future therapies
J Cardiol. 2022 Jan 8:S0914-5087(21)00365-8. doi: 10.1016/j.jjcc.2021.12.010. Online ahead of print.ABSTRACTA shift to lifetime management has gained more focus with the approval of low-risk transcatheter aortic valve replacement (TAVR). This paper is therefore focused on the different approaches for lifetime management. Herein we discuss the procedural safety, durability, performance, and future options for each lifetime management strategy. In younger patients that elect to undergo surgical aortic valve replacement (SAVR), options for bioprosthetic failure are TAV-in-SAV or redo SAVR. Among patients that undergo TAVR, op...
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Craig Basman Luigi Pirelli Varinder P Singh Carl D Reimers Jonathan Hemli Derek R Brinster Nirav C Patel S Jacob Scheinerman Chad A Kliger Source Type: research

Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling
CONCLUSIONS: The use of AdaptivCRT was projected to improve average patient survival and avoid costs in a Japanese healthcare setting.PMID:35016809 | DOI:10.1016/j.jjcc.2021.12.016 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Takashi Noda Xiaoxiao Lu Yoko Ishiguro Joshua Ikuemonisan Reece Holbrook Stelios Tsintzos Kengo Kusano Source Type: research

A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio
CONCLUSIONS: The cGMP to emBNP ratio could be utilized as a predictive biomarker of CRT responders. (Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide: UMIN R000038927).PMID:35016810 | DOI:10.1016/j.jjcc.2021.12.015 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Yasuhiro Yokoyama Naoya Kataoka Michikazu Nakai Ayaka Matsuo Akihiro Fujiwara Akinori Wakamiya Nobuhiko Ueda Kenzaburo Nakajima Tsukasa Kamakura Mitsuru Wada Kenichiro Yamagata Kohei Ishibashi Yuko Inoue Koji Miyamoto Satoshi Nagase Takashi Noda Takeshi A Source Type: research

Lifetime management for aortic stenosis: Planning for future therapies
J Cardiol. 2022 Jan 8:S0914-5087(21)00365-8. doi: 10.1016/j.jjcc.2021.12.010. Online ahead of print.ABSTRACTA shift to lifetime management has gained more focus with the approval of low-risk transcatheter aortic valve replacement (TAVR). This paper is therefore focused on the different approaches for lifetime management. Herein we discuss the procedural safety, durability, performance, and future options for each lifetime management strategy. In younger patients that elect to undergo surgical aortic valve replacement (SAVR), options for bioprosthetic failure are TAV-in-SAV or redo SAVR. Among patients that undergo TAVR, op...
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Craig Basman Luigi Pirelli Varinder P Singh Carl D Reimers Jonathan Hemli Derek R Brinster Nirav C Patel S Jacob Scheinerman Chad A Kliger Source Type: research

Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling
CONCLUSIONS: The use of AdaptivCRT was projected to improve average patient survival and avoid costs in a Japanese healthcare setting.PMID:35016809 | DOI:10.1016/j.jjcc.2021.12.016 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Takashi Noda Xiaoxiao Lu Yoko Ishiguro Joshua Ikuemonisan Reece Holbrook Stelios Tsintzos Kengo Kusano Source Type: research

A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio
CONCLUSIONS: The cGMP to emBNP ratio could be utilized as a predictive biomarker of CRT responders. (Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide: UMIN R000038927).PMID:35016810 | DOI:10.1016/j.jjcc.2021.12.015 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Yasuhiro Yokoyama Naoya Kataoka Michikazu Nakai Ayaka Matsuo Akihiro Fujiwara Akinori Wakamiya Nobuhiko Ueda Kenzaburo Nakajima Tsukasa Kamakura Mitsuru Wada Kenichiro Yamagata Kohei Ishibashi Yuko Inoue Koji Miyamoto Satoshi Nagase Takashi Noda Takeshi A Source Type: research

Lifetime management for aortic stenosis: Planning for future therapies
J Cardiol. 2022 Jan 8:S0914-5087(21)00365-8. doi: 10.1016/j.jjcc.2021.12.010. Online ahead of print.ABSTRACTA shift to lifetime management has gained more focus with the approval of low-risk transcatheter aortic valve replacement (TAVR). This paper is therefore focused on the different approaches for lifetime management. Herein we discuss the procedural safety, durability, performance, and future options for each lifetime management strategy. In younger patients that elect to undergo surgical aortic valve replacement (SAVR), options for bioprosthetic failure are TAV-in-SAV or redo SAVR. Among patients that undergo TAVR, op...
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Craig Basman Luigi Pirelli Varinder P Singh Carl D Reimers Jonathan Hemli Derek R Brinster Nirav C Patel S Jacob Scheinerman Chad A Kliger Source Type: research

Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling
CONCLUSIONS: The use of AdaptivCRT was projected to improve average patient survival and avoid costs in a Japanese healthcare setting.PMID:35016809 | DOI:10.1016/j.jjcc.2021.12.016 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Takashi Noda Xiaoxiao Lu Yoko Ishiguro Joshua Ikuemonisan Reece Holbrook Stelios Tsintzos Kengo Kusano Source Type: research

A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio
CONCLUSIONS: The cGMP to emBNP ratio could be utilized as a predictive biomarker of CRT responders. (Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide: UMIN R000038927).PMID:35016810 | DOI:10.1016/j.jjcc.2021.12.015 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Yasuhiro Yokoyama Naoya Kataoka Michikazu Nakai Ayaka Matsuo Akihiro Fujiwara Akinori Wakamiya Nobuhiko Ueda Kenzaburo Nakajima Tsukasa Kamakura Mitsuru Wada Kenichiro Yamagata Kohei Ishibashi Yuko Inoue Koji Miyamoto Satoshi Nagase Takashi Noda Takeshi A Source Type: research

Lifetime management for aortic stenosis: Planning for future therapies
J Cardiol. 2022 Jan 8:S0914-5087(21)00365-8. doi: 10.1016/j.jjcc.2021.12.010. Online ahead of print.ABSTRACTA shift to lifetime management has gained more focus with the approval of low-risk transcatheter aortic valve replacement (TAVR). This paper is therefore focused on the different approaches for lifetime management. Herein we discuss the procedural safety, durability, performance, and future options for each lifetime management strategy. In younger patients that elect to undergo surgical aortic valve replacement (SAVR), options for bioprosthetic failure are TAV-in-SAV or redo SAVR. Among patients that undergo TAVR, op...
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Craig Basman Luigi Pirelli Varinder P Singh Carl D Reimers Jonathan Hemli Derek R Brinster Nirav C Patel S Jacob Scheinerman Chad A Kliger Source Type: research

Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling
CONCLUSIONS: The use of AdaptivCRT was projected to improve average patient survival and avoid costs in a Japanese healthcare setting.PMID:35016809 | DOI:10.1016/j.jjcc.2021.12.016 (Source: Journal of Cardiology)
Source: Journal of Cardiology - January 12, 2022 Category: Cardiology Authors: Takashi Noda Xiaoxiao Lu Yoko Ishiguro Joshua Ikuemonisan Reece Holbrook Stelios Tsintzos Kengo Kusano Source Type: research